Chromatographia

, Volume 69, Issue 5–6, pp 555–560 | Cite as

LC Fingerprinting for Assessment of the Quality of the Lipophilic Components of Salvia miltiorrhiza

Full Short Communication
First Online:
Received:
Revised:
Accepted:

Abstract

With an appropriate method of fingerprinting, and by analysis of three marker compounds, the factors affecting the lipophilic components in Salvia miltiorrhiza were investigated in this work. A standard fingerprint of the lipophilic components of root periderm was constructed at 270 nm and a limited number of marker compounds were proposed on the basis of ten batches of S. miltiorrhiza from Shangluo GAP (good agricultural practice) base. The absolute amounts of these components in S. miltiorrhiza were seriously affected by production area, harvest time, root disease, root color, and root diameter. Relative amounts were, however, consistent under different conditions. Accumulation of some components peaked in August and was significantly accelerated by diseases such as root rot and nematodiasis. The red roots were the best quality, compared with sable and yellowish roots. The quality of roots of different diameter was variable. For example, among seven groups of samples it was best for roots of diameter <0.2 cm and between 0.5 and 0.8 cm, and worst for root heads and fibrous roots. In conclusion, the quality of the lipophilic components of S. miltiorrhiza was comprehensively assessed.

Keywords

Column liquid chromatography Salvia miltiorrhiza Bunge Lamiaceae Quality assessment Lipophilic component Fingerprinting 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

Financial support from the knowledge innovation project of Chinese Academy of Science (KZCX2-XB2-05-01) and the National 11th Five-Year Key Technology R&D Program (2007BAD79B06) is greatly appreciated.

References

  1. 1.
    Lei XL, Chiou GC (1986) Am J Chin Med 14:145–152. doi: 10.1142/S0192415X86000235 CrossRefGoogle Scholar
  2. 2.
    Lu YR, Foo LY (2002) Phytochem 59:117–140. doi: 10.1016/S0031-9422(01)00415-0 CrossRefGoogle Scholar
  3. 3.
    Wu YJ, Hong CY, Lin SJ, Wu P, Shiao MS (1998) Arterioscl Throm Vas 18:481–486Google Scholar
  4. 4.
    Yagi A, Fujimoto K, Tanonaka K, Hirai K, Takeo S (1989) Planta Med 55:51–54. doi: 10.1055/s-2006-961824 CrossRefGoogle Scholar
  5. 5.
    Datta P, Dasgupta A (2002) Ther Drug Monit 24:634–637. doi: 10.1097/00007691-200210000-00010 CrossRefGoogle Scholar
  6. 6.
    Sugiyama A, Zhu B, Takahara A, Satoh Y, Hashimoto K (2002) Circ J 66:182–184. doi: 10.1253/circj.66.182 CrossRefGoogle Scholar
  7. 7.
    Nan JX, Park EJ, Kang HC, Park PH, Kim JY, Sohn DH (2001) J Pharm Pharmacol 53:194–197. doi: 10.1211/0022357011775406 CrossRefGoogle Scholar
  8. 8.
    Ryu SY, No ZS, Kim SH, Ahn JW (1997) Planta Med 63:44–46. doi: 10.1055/s-2006-957601 CrossRefGoogle Scholar
  9. 9.
    Ikeshiro Y, Hashimoto I, Iwamoto Y, Mase I, Tomita Y (1991) Phytochemistry 30:2791–2792. doi: 10.1016/0031-9422(91)85147-R CrossRefGoogle Scholar
  10. 10.
    An LK, Bu XZ, Wu HQ, Guo XD, Ma L, Gu LQ (2002) Tetrahedron 58:10315–10321. doi: 10.1016/S0040-4020(02)01414-X CrossRefGoogle Scholar
  11. 11.
    Kasimu R, Tanaka K, Tezuka Y, Gong ZN, Li JX, Basnet P, Namba T, Kadota S (1998) Chem Pharm Bull (Tokyo) 46:500–504Google Scholar
  12. 12.
    Cao EH, Liu XQ, Wang JJ, Xu NF (1996) Free Radic Biol Med 20:801–806. doi: 10.1016/0891-5849(95)02211-2 CrossRefGoogle Scholar
  13. 13.
    Zhou LM, Zuo Z, Chow MSS (2005) J Clin Pharmacol 45:1345–1359. doi: 10.1177/0091270005282630 CrossRefGoogle Scholar
  14. 14.
    Lee DS, Lee SH, Kwon GS, Lee HK, Woo JH, Kim JG, Hong SD (1999) Biosci Biotechnol Biochem 63:1370–1383. doi: 10.1271/bbb.63.1370 CrossRefGoogle Scholar
  15. 15.
    Lee DS, Lee SH (2000) J Biosci Bioeng 89:292–293. doi: 10.1016/S1389-1723(00)88838-6 CrossRefGoogle Scholar
  16. 16.
    Liang YZ, Xie PS, Chan K (2004) J Chromatogr B Analyt Technol Biomed Life Sci 812:53–70Google Scholar
  17. 17.
    Hu P, Luo GA, Zhao ZZ, Jiang ZH (2005) Chem Pharm Bull (Tokyo) 53:481–486. doi: 10.1248/cpb.53.481 CrossRefGoogle Scholar
  18. 18.
    Gu M, Ouyang F, Su ZG (2004) J Chromatogr A 1022:139–144. doi: 10.1016/j.chroma.2003.09.038 CrossRefGoogle Scholar
  19. 19.
    Gu M, Zhang SF, Su ZG, Chen Y, Ouyang F (2004) J Chromatogr A 1057:133–140. doi: 10.1016/j.chroma.2004.08.145 CrossRefGoogle Scholar
  20. 20.
    Gu M, Su ZG, Ouyang F (2006) J Liquid Chromatogr Relat Technol 29:1503–1514. doi: 10.1080/10826070600674968 CrossRefGoogle Scholar
  21. 21.
    Ma LJ, Zhang XZ, Zhang HP, Gan YR (2006) J Chromatogr B Analyt Technol Biomed Life Sci 846:139–146Google Scholar
  22. 22.
    Hu P, Liang QL, Luo GA, Jiang ZH (2005) Chem Pharm Bull (Tokyo) 53:677–683. doi: 10.1248/cpb.53.677 CrossRefGoogle Scholar
  23. 23.
    Liu AH, Lin YH, Yang M, Guo H, Guan SH, Sun JH, Guo DA (2007) J Chromatogr B Analyt Technol Biomed Life Sci 846:32–41. doi: 10.1016/j.jchromb.2006.08.002 CrossRefGoogle Scholar
  24. 24.
    Zhou LM, Chow M, Zuo Z (2006) J Pharm Biomed 41:744–750. doi: 10.1016/j.jpba.2005.12.032 CrossRefGoogle Scholar
  25. 25.
    State Drug Administration of China (2000) Chin Tradit Pat Med 22:671–675Google Scholar

Copyright information

© Vieweg+Teubner | GWV Fachverlage GmbH 2008

Authors and Affiliations

  • Dong-Feng Yang
    • 1
    • 2
  • Zong-Suo Liang
    • 1
    • 2
  • Jian-Lin Liu
    • 1
    • 2
  1. 1.College of Life Science of Northwest A&F UniversityYanglingChina
  2. 2.Shaanxi Research Center in TCM Fingerprint and NP LibraryYanglingChina

Personalised recommendations